Skip to main content

2 April 2026

Last updated: Thursday 2 April 2026

User account anon menu

Login
Register and subscribe

Search

Home
News
About MedNous
Research Directory
Contact Us
- Contact Form

Menu

Breadcrumb

Home
Research Directory

Research Directory

Direct cell reprogramming: Mogrify and Astellas to address hearing loss

Wednesday 14 September 2022

Interviewee/Contributor

Louise Modis

Organisation

Mogrify Ltd

Technology for direct cell reprogramming

Tuesday 10 September 2019

Interviewee/Contributor

Julian Gough

Organisation

Mogrify Ltd

Organisations

BC Platforms AG
Bellevue Asset Management
Massachusetts General Hospital
Autifony Therapeutics Ltd
On-Kòs Pharma Consulting
Shore Capital Ltd
Abingworth LLP
Oxford Biomedica Plc
GE Healthcare
Independent healthcare analyst

Interviewees and Contributers

Jan-Anders Karlsson
Renée Aguiar-Lucander
Jennifer Bailey
Angelika Joos
Kevin Cox
Mark Rothera
Alcide Barberis
Stefanos Theoharis
Gerard Brandon
Michael Nowak

Select a News Category

Clinical Research
Company News
Finance, Grants, Deals
IPR & Legal
Regenerative Medicine
Regulation & Policy
Research & University News

Recent Appointments

Poolbeg Pharma names drug developer to SAB

Saturday 14 March 2026

Commit Biologics names biotech entrepreneur as CEO

Saturday 14 March 2026

Orexo changes management in strategic shift

Saturday 14 March 2026

New CFO at Beacon Therapeutics

Saturday 14 March 2026

4basebio names new COO and CCO, strengthens commercial team

Saturday 14 March 2026

View more appointments

Looking for more?

MedNous covers medical news and more. See more in our various site sections.

News
Industry appointments
Events
Research directory
Subscribe

Footer

Privacy policy

© 2026 Evernow Publishing Ltd.

Home
News
- News
- Appointments
- Events
About MedNous
Research Directory
Contact Us
- Contact Form